NEW YORK, Feb. 20, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Tissue Engineering: The Combination of Cells & Engineering - A Global Market Overview

http://www.reportlinker.com/p0774604/Tissue-Engineering-The-Combination-of-Cells--Engineering---A-Global-Market-Overview.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biological_Therapy

Advancements of novel therapies in the fields of tissue engineering and regenerative medicine have opened up new avenues for addressing a range of major diseases such as cancer; skin; cardiovascular conditions; urology; dental; neurological disorders including Alzheimer's and Parkinson's; and other. Engineered tissues can be successfully constructed through the recreation of a biologically active extracellular environment in which the product can be developed. These technologies offer new hope for medical progress, and the economies of emerging nations have recognized the potential of tapping into these fast emerging fields to gain maximum mileage.

The global market for the therapeutic areas of Tissue Engineering analyzed in this study comprises Orthopedics, Integumentary, Oncology, Cardiology, Dental, Neurology and Other. Individual regions analyzed in the study includes the United States, Europe, Asia-Pacific and Rest of World. Estimated to value US$11 billion in 2012, the global market for tissue engineering is expected to touch US$27 billion by 2018.

This 153 page global market report includes 27 rich data tables, supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the global market value by geographic regions and application areas.

The report covers the brief business profiles of 60 major players across the United States – 47; Europe – 10; Asia-Pacific – 2; and Rest of World – 1. The report also provides the listing of the companies engaged in the business related to Tissue Engineering. The global list covers the addresses, contact numbers and the website addresses of 364 companies.

TABLE OF CONTENTS: 1. INTRODUCTION2. PRODUCT OUTLINE 2.1 Biomaterials

2.2 Cells

2.3 Biomolecules

2.4 Aspects of Engineering Design

2.5 Biomechanical Design Aspects

2.6 Informatics to Support Tissue Engineering

2.7 Stem Cell Research

2.8 Therapeutic Applications of Tissue Engineering and Regenerative Medicine

2.8.1 Orthopedic Applications

2.8.1.1 Bone Regeneration Using Orthopedic Tissue Engineering

2.8.1.2 Articular Cartilage Degeneration and Osteoarthritis, Repair, Regeneration and Transplantation

2.8.1.2.1 Cartilage Repair

2.8.1.2.2 Osteochondral Allograft Transplantation

2.8.2 Skin/Integumentary Applications

2.8.2.1 Burns

2.8.2.2 Diabetic Ulcers

2.8.2.3 Venous Ulcers

2.8.2.4 Plastic and Reconstructive Surgery

2.8.3 Oncology Applications

2.8.3.1 Cancer

2.8.3.2 Cancer Biology from Tissue Engineering's Perspective

2.8.3.3 Tissue Engineering Technology Platforms' Translation into Cancer Research

2.8.4 Cardiovascular Applications

2.8.4.1 Cardiac Tissue Engineering: An Overview

2.8.4.2 Identification of Basic Cell Responses

2.8.4.2.1 Materials and Degradation

2.8.4.2.2 Attachment

2.8.4.2.3 Stiffness

2.8.4.2.4 Diffusion and Porosity

2.8.4.2.5 Forces

2.8.4.3 3-Dimensional Tissue Engineering

2.8.4.4 Further 3-D Approaches and Considerations

2.8.4.5 Cardiovascular Tissue Engineering and Bioreactor Technology

2.8.4.6 Limiting Cells or Materials

2.8.5 Dental

2.8.5.1 Dental Tissue Regeneration through Tissue Engineering Strategy

2.8.5.2 Harvesting Teeth Created by Tissue Engineering

2.8.5.3 Research Goals Currently Targeted

2.8.5.4 Process of Tissue Engineering for Tooth Replacement: What Future Trends Indicate

2.8.6 Neurology Applications

2.8.6.1 Neural Tissue Engineering or Neuroregeneration

2.8.6.2 Biomaterial Scaffold Development for Nerve Tissue Engineering: Biomaterial Mediated Neural Regeneration

2.8.6.2.1 Response to Injury and Repair

2.8.6.2.2 Neural Cells' Regeneration Potential

2.8.6.2.3 Regeneration Promoted through Growth Factor Delivery

2.8.6.2.4 Biomaterials in Nerve Regeneration

2.8.6.2.5 Polymeric Scaffolds as Extracellular Matrix Analogues

2.8.6.2.6 Geometric Indicators: Structure of Scaffolds

2.8.6.2.7 Nanofiber Properties and Electrospinning Technology

2.8.6.2.8 Alternate Approaches

2.8.6.2.9 Electrical Cues

2.8.7 Urological Applications

2.8.7.1 Conditions Affecting the Urological System

2.8.7.1.1 The Kidney

2.8.7.1.2 The Ureter

2.8.7.1.3 The Urinary Bladder

2.8.7.1.4 The Urinary Sphincters

2.8.7.1.5 The Urethra

2.8.7.2 Stem Cells Offering Promise in Urological Regenerative Medicine

2.8.7.3 Polymeric Materials and their Potential Applications in Urologic Regenerative Medicine

2.8.8 Organ Transplantation

2.8.8.1 Categories of Transplant

2.8.8.2 Major Organs and Tissues Transplanted

3. KEY MARKET TRENDS What Lies in Store for Cartilage Regeneration Stem Cells

Improved Scaffold for Bone Tissue Engineering Developed by Iranian Researchers

Magnetic Levitation for Bio-Assembling in 3-D

UK's Footing in Regenerative Medicine Gaining Pace

Chondrogenesis and Cartilage Tissue Engineering: The Way Ahead

Regenerative Medicine Evolving, though Investors Still Wary

Scientific Innovation Announced by LifeNet Health's Institute of Regenerative Medicine

Skin Stem Cells to Cure Genetic Liver Disease

Future Markets for Tissue Engineering and Cell Therapy

Timescale for Development

Tissue Engineering and Ultrasound Technologies

Overview of Myocardial Tissue Engineering (MTE)

Future of Bone Regeneration and Organ Printing

New Tissue Engineering Technology on the Way for Patients with Osteoarthritis

Leg Muscle Regenerated from Pig Bladder Cells

Loading Device for Intervertebral Disc Tissue Engineering

Rodent Spine Biomechanical Function Restored with Tissue-Engineered Intervertebral Discs

Engineering Human Tissue Regeneration via Novel Method

Heart Tissue Healing Assisted by New Nanotechnology

Developing Bioengineered Veins with Tissue Engineered Vascular Grafts a Promising Prospect

New Organs, New Hope for Children Offered by Regenerative Medicine

TERM: A Consortium Formed by Eight European Regions to Focus on Bolstering Tissue Engineering and Regenerative Medicine Initiatives

An Overview of Dental Pulp Tissue Engineering

Bioactive Electrospun Scaffolds to Deliver Growth Factors and Genes for Tissue Engineering Applications

Regenerative Medicine: Progress and Prospects

"Bio-Legos": An Innovation in Tissue Engineering

Pioneering Tissue-Engineered Urethras Report Success

4. MAJOR MARKET PLAYERS Advanced Cell Technology Inc

Aesculap/B. Braun

Athersys Inc

Baxter International Inc

Bayer Healthcare Pharmaceuticals

Biocomposites Ltd

Biolife Solutions Inc

Biomet Inc

Biotissue Technologies GmbH

Cardium Therapeutics

Celgene Corporation

Cellerant Therapeutics Inc

Corcell Companies, Inc

Cryobanks International Inc

Cryo-Cell International, Inc

Cryolife, Inc

Cryo-Save Group N.V.

Cytori Therapeutics Inc

Depuy

Eli Lilly and Co

ES Cell International Pte Ltd

Gamida Cell Ltd

Genta, Inc

Genzyme Biosurgery Corp

Genzyme Corp

Geron Corporation

Glaxosmithkline Plc

Histogenics Corp

Incytu Inc

Integra Lifesciences Inc

International Stem Cell Corporation

Johnson & Johnson Inc

Kensey Nash

Kinetic Concepts, Inc.

Lifecell Corp

Lifecord International Co Ltd

Medtronic Sofamor Danek Inc

Neostem, Inc.

Novartis Ag

Novo Nordisk A/S

Organogenesis Inc.

OSI Pharmaceuticals Inc

Osiris Therapeutics Inc.

Osteotech, Inc.

Pfizer Inc

Regenerative Sciences Institute

RTI Biologics, Inc

Sanofi-Aventis

Smith & Nephew Ltd

Stryker Corporation

Synovis Life Technologies, Inc

Synovis Orthopedic and Woundcare, Inc

Tengion, Inc

Thermogenesis Corp

Tissue Engineering, Inc.

Tissue Repair Company

Viacord

Viacyte, Inc.

W.L. Gore & Associates

Zimmer Holdings Inc

5. KEY BUSINESS TRENDS NeoStem Completes Amorcyte Acquisition

British Stem Cell Center Given the Go Ahead

Aragon Surgical, Inc Taken Over by Aesculap

Cellectis Acquires Cellartis

Advanced BioHealing, Inc Acquired by Shire plc

ProChon BioTech Acquired by Histogenics

Integra LifeSciences Takes Over SeaSpine

Stryker Acquires Orthovita

Medtronic's Minority Stake in Tengion with a Focus on Regenerative Medicine Market

Cardiogenesis Acquired by CryoLife

Trial for Stem Cell-Based Therapy for IBD Commenced by Athersys-Pfizer

BioTime Acquires Glycosan BioSystems

Two Innovative Technologies Acquired by Boston Scientific

Allograft Cancellous Sponge Introduced by Integra LifeSciences

Eli Lilly in Partnership with the Juvenile Diabetes Research Foundation

Cell Targeting, Inc Acquired by BioTime

Boston Scientific Acquires Atritech

Intelect Medical Taken Over by Boston Scientific

Progenitor Cell Therapy Taken Over by NeoStem

Avid Radiopharmaceuticals Taken Over by Eli Lilly

Integra™ Endoscopic Gastroc Release System (EGR) Launched by Integra LifeSciences

Integra LifeSciences Launches New Range of Surgical Spine Instruments

Lilly Acquires Alnara Pharmaceuticals

Celgene Acquires Abraxis BioScience Inc

First Regenerative Medicine Product from Harvard Bioscience

Novel Bioactive Scaffold from Drexel

6. GLOBAL MARKET OVERVIEW 6.1 Global Market Analysis by Therapeutic Area

Chart 1: Global Tissue Engineering Market Analysis (2008-2018) by Therapeutic Area – Orthopedics, Integumentary, Oncology, Cardiology, Dental, Neurology and Other in USD Million

Chart 2: Glance at 2008, 2013 and 2018 Global Tissue Engineering Market Share (%) by Therapeutic Area – Orthopedics, Integumentary, Oncology, Cardiology, Dental, Neurology and Other

6.2 Tissue Engineering Therapeutic Area Analysis by Global Region 6.2.1 Orthopedics

Chart 3: Global Market Analysis of Tissue Engineering in Orthopedic Applications (2008-2018) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD Million

Chart 4: Glance at 2008, 2013 and 2018 Global Market Share (%) of Tissue Engineering in Orthopedic Applications by Geographic Region – United States, Europe, Asia-Pacific and Rest of World

6.2.2 IntegumentaryChart 5: Global Market Analysis of Tissue Engineering in Integumentary Applications (2008-2018) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD MillionChart 6: Glance at 2008, 2013 and 2018 Global Market Share (%) of Tissue Engineering in Integumentary Applications by Geographic Region – United States, Europe, Asia-Pacific and Rest of World

6.2.3 Oncology

Chart 7: Global Market Analysis of Tissue Engineering in Oncology Applications (2008-2018) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD Million

Chart 8: Glance at 2008, 2013 and 2018 Global Market Share (%) of Tissue Engineering in Oncology Applications by Geographic Region – United States, Europe, Asia-Pacific and Rest of World

6.2.4 CardiologyChart 9: Global Market Analysis of Tissue Engineering in Cardiology Applications (2008-2018) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD MillionChart 10: Glance at 2008, 2013 and 2018 Global Market Share (%) of Tissue Engineering in Cardiology Applications by Geographic Region – United States, Europe, Asia-Pacific and Rest of World

6.2.5 Dental

Chart 11: Global Market Analysis of Tissue Engineering in Dental Applications (2008-2018) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD Million

Chart 12: Glance at 2008, 2013 and 2018 Global Market Share (%) of Tissue Engineering in Dental Applications by Geographic Region – United States, Europe, Asia-Pacific and Rest of World

6.2.6 NeurologyChart 13: Global Market Analysis of Tissue Engineering in Neurology Applications (2008-2018) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD MillionChart 14: Glance at 2008, 2013 and 2018 Global Market Share (%) of Tissue Engineering in Neurology Applications by Geographic Region – United States, Europe, Asia-Pacific and Rest of World

6.2.7 Other Therapeutic Areas

Chart 15: Global Market Analysis of Tissue Engineering in Other Therapeutic Applications (2008-2018) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD Million

Chart 16: Glance at 2008, 2013 and 2018 Global Market Share (%) of Tissue Engineering in Other Therapeutic Applications by Geographic Region – United States, Europe, Asia-Pacific and Rest of World

7. REGIONAL MARKET OVERVIEW Chart 17: The Projection of Key Market Region in terms of Growth for Tissue Engineering by Geography – Asia-Pacific, South America, Europe and North America

Chart 18: Global Tissue Engineering Market Analysis (2008-2018) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD Million

Chart 19: Glance at 2008, 2013 and 2018 Global Tissue Engineering Market Share (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World

7.1 THE UNITED STATESChart 20: United States Tissue Engineering Market Analysis (2008-2018) by Therapeutic Area – Orthopedics, Integumentary, Oncology, Cardiology, Dental, Neurology and Other in USD MillionChart 21: Glance at 2008, 2013 and 2018 United States Tissue Engineering Market Share (%) by Therapeutic Area – Orthopedics, Integumentary, Oncology, Cardiology, Dental, Neurology and Other

7.2 EUROPE

Chart 22: Western Europe Tissue Engineering Market Analysis (2008-2018) by Therapeutic Area – Orthopedics, Integumentary, Oncology, Cardiology, Dental, Neurology and Other in USD Million

Chart 23: Glance at 2008, 2013 and 2018 Western Europe Tissue Engineering Market Share (%) by Therapeutic Area – Orthopedics, Integumentary, Oncology, Cardiology, Dental, Neurology and Other

7.3 ASIA-PACIFICChart 24: Asia-Pacific Tissue Engineering Market Analysis (2008-2018) by Therapeutic Area – Orthopedics, Integumentary, Oncology, Cardiology, Dental, Neurology and Other in USD MillionChart 25: Glance at 2008, 2013 and 2018 Asia-Pacific Tissue Engineering Market Share (%) by Therapeutic Area – Orthopedics, Integumentary, Oncology, Cardiology, Dental, Neurology and Other

7.4 REST OF WORLD

Chart 26: Rest of World Tissue Engineering Market Analysis (2008-2018) by Therapeutic Area – Orthopedics, Integumentary, Oncology, Cardiology, Dental, Neurology and Other in USD Million

Chart 27: Glance at 2008, 2013 and 2018 Rest of World Tissue Engineering Market Share (%) by Therapeutic Area – Orthopedics, Integumentary, Oncology, Cardiology, Dental, Neurology and Other

8. GUIDE TO THE INDUSTRY 8.1 North America

8.1.1 Canada

8.1.2 United States

8.2 Europe8.2.1 Belgium8.2.2 Cyprus8.2.3 Denmark8.2.4 Finland8.2.5 France8.2.6 Germany8.2.7 Iceland8.2.8 Ireland8.2.9 Italy8.2.10 Luxembourg8.2.11 Spain8.2.12 Sweden8.2.13 Switzerland8.2.14 The Netherlands8.2.15 Turkey8.2.16 United Kingdom

8.3 Asia-Pacific

8.3.1 Australia

8.3.2 China

8.3.3 Hong Kong

8.3.4 India

8.3.5 Japan

8.3.6 Malaysia

8.3.7 New Zealand

8.3.8 Singapore

8.3.9 South Korea

8.4 Rest of World8.4.1 Argentina8.4.2 Israel 9. ANNEXURE 9.1 Research Methodology9.2 The Questionnaire9.3 FeedbackTo order this report: Biological Therapy Industry: Tissue Engineering: The Combination of Cells & Engineering - A Global Market Overview

More  Market Research Report

Check our  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

Back to top

RELATED LINKS
http://www.reportlinker.com